Hepatitis Treatment Center
A premier outpatient program offering comprehensive management and treatment of individuals with viral hepatitis.
Who is Affected by Hepatitis?
An estimated 700,000 to 1.4 million people in the United States have chronic hepatitis B and 240 million people globally are chronically infected with Hepatitis B. Rates are highest in the United States among adults, particularly males aged 25–44 years (CDC, 2016). Hepatitis C affects nearly 3.2 million people in the United States, and about 150 million people are chronically infected worldwide. Hepatitis C is the leading cause of liver failure and end stage liver disease. (ALF, 2016). Chronic HCV infection is also the leading indication for liver transplants in the United States (CDC, 2016). It is a curable disease and thus need to screen and treat early is emphasized. Screening is most easily done using a simple blood test. This can be facilitated by your primary care physician. Currently there is no vaccine available for hepatitis C.